SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
In this review, we summarise the cardiac manifestations of COVID-19 infection and propose a simplified algorithm for patient management during the COVID-19 pandemic.
Risk of COVID-19 Among Front-Line Health-Care Workers and the General Community: A Prospective Cohort Study.
Health-care systems should ensure adequate availability of PPE and develop additional strategies to protect health-care workers from COVID-19, particularly those from Black, Asian, and minority ethnic backgrounds.
Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers
These guidelines are not meant to replace sound clinical judgment or specialist consultation but rather to strengthen provision and clinical management of ECMO specifically, in the context of the COVID-19 pandemic.
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Besides the anticoagulant effect of LMWH, nonanticoagulant properties such as the reduction in interleukin 6 release have been shown to improve the complex picture of coagulopathy in patients with COVID-19.
Has Venoarterial Ecmo Been Underutilized in Covid-19 Patients?
This outbreak of infectious disease could enable an improved understanding of ARDS and a more precise use of therapeutics as ECMO and different configurations with a tailor-made treatment.
Education and Scientific Dissemination during the Covid-19 Pandemic
This editorial outlines how education and scientific dissemination at the Association of Anaesthetists has continued throughout the pandemic, as well as exploring likely future directions for such activities.
Perioperative Management of COVID-19 Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
The following report will recommend perioperative guidance in patient management to include safety precautions for the heart team, the conduct of extracorporeal circulation and related equipment, and covering the early period in intensive care in the context of the current pandemic.
Cytokine Adsorption in Patients with Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
With this study, we expect to clarify whether cytokine adsorption is beneficial in severely affected COVID-19 patients requiring vv-ECMO support.
American Experience with Extracorporeal Support in Covid-19 Patients: Early Outcomes from a Single Institution
As the world learned about Covid-19, the application of ECMO also evolved as health systems in the United States had some time to prepare. We report our initial experience using extracorporeal support for Covid-19 patients with the resource challenges that attend a worldwide pandemic.
Thrombosis and Coagulopathy in COVID‐19: An Illustrated Review
There appear to be high rates of venous thromboembolism and also, what has been poorly described before in acute lung injury, a high rate of pulmonary immunothrombosis (thrombosis secondary to inflammation).
Is a “Cytokine Storm” Relevant to COVID-19?
A critical evaluation of the term cytokine storm and its relevance to COVID-19 is warranted.
The role of ECMO in COVID-19: Can it Provide Rescue Therapy in Those Who Are Critically Ill?
Our understanding of COVID‐19 is ever‐changing and the need for intensive care beds is rising, which means that ECMO will surely play a key role in the near future.